A Prospective, Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis.

Trial Profile

A Prospective, Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 09 Feb 2010

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Angina pectoris; Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia; Restenosis
  • Focus Therapeutic Use
  • Acronyms TAXUS-V-ISR
  • Sponsors Boston Scientific Corporation
  • Most Recent Events

    • 09 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Mar 2009 Results presented at the 58th Annual Scientific Session of the American College of Cardiology (ACC-2009).
    • 30 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top